FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000479721> ?p ?o ?g. }

• W2000479721 endingPage "30" @default.
• W2000479721 startingPage "22" @default.
• W2000479721 abstract "Cognitive dysfunction is more common in individuals with type 2 diabetes (T2DM). Currently, glucagon-like peptide-1 (GLP-1) and metformin are important therapeutic options for patients with T2DM. However, their potential effects on cognitive function, including underlying mechanisms, are yet to be fully determined. We have compared the individual and combined effects of treatment for 20 days with (Val8)GLP-1(GluPAL), an enzymatically stable GLP-1-receptor agonist, and metformin on metabolic control and aspects of learning and memory in high fat fed mice. (Val8)GLP-1(GluPAL) treatment for 20 days alone, or in combination with metformin, improved (p < 0.05) the recognition index in high fat mice, indicating enhanced learning and memory. In addition, these mice exhibited a complete reversal of the deleterious effects of prolonged high-fat feeding on long-term potentiation in the hippocampal CA1 region. This was linked to reduced hippocampal levels of 8-oxoguanine (p < 0.01) and glial fibriallary acidic protein (p < 0.001), indicating decreased oxidative stress and inflammation; respectively. Expression of fundamental hippocampal genes including mTOR, VEGF, NTRK2 and SIRT1 was also increased significantly (p < 0.001) by all treatments. (Val8)GLP-1(GluPAL) monotherapy, or in combination with metformin, reduced circulating glucose (p < 0.05) and increased insulin (p < 0.05 to p < 0.01) concentrations, as well as improving glucose tolerance (p < 0.001) and glucose-stimulated insulin secretion (p < 0.05 to p < 0.01). Insulin sensitivity and measurements of energy regulation and metabolic rate were not altered. These studies highlight the neuroprotective properties of (Val8)GLP-1(GluPAL), alone and in combination with metformin, in T2DM." @default.
• W2000479721 created "2016-06-24" @default.
• W2000479721 creator A5001545372 @default.
• W2000479721 creator A5013136657 @default.
• W2000479721 creator A5037057754 @default.
• W2000479721 creator A5075620817 @default.
• W2000479721 creator A5081142951 @default.
• W2000479721 creator A5082707086 @default.
• W2000479721 date "2014-11-01" @default.
• W2000479721 modified "2023-10-12" @default.
• W2000479721 title "Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice" @default.
• W2000479721 cites W1659775087 @default.
• W2000479721 cites W1668720646 @default.
• W2000479721 cites W1918909705 @default.
• W2000479721 cites W1964423574 @default.
• W2000479721 cites W1979100644 @default.
• W2000479721 cites W1980944036 @default.
• W2000479721 cites W1983644247 @default.
• W2000479721 cites W1984170856 @default.
• W2000479721 cites W1984551681 @default.
• W2000479721 cites W1990064667 @default.
• W2000479721 cites W1990306590 @default.
• W2000479721 cites W1990441398 @default.
• W2000479721 cites W1994063542 @default.
• W2000479721 cites W1995897557 @default.
• W2000479721 cites W2013687768 @default.
• W2000479721 cites W2015569637 @default.
• W2000479721 cites W2016932677 @default.
• W2000479721 cites W2017266270 @default.
• W2000479721 cites W2022260186 @default.
• W2000479721 cites W2023542419 @default.
• W2000479721 cites W2028325626 @default.
• W2000479721 cites W2036284058 @default.
• W2000479721 cites W2037428028 @default.
• W2000479721 cites W2037520056 @default.
• W2000479721 cites W2044940977 @default.
• W2000479721 cites W2046949772 @default.
• W2000479721 cites W2050875709 @default.
• W2000479721 cites W2053068006 @default.
• W2000479721 cites W2053140710 @default.
• W2000479721 cites W2055361873 @default.
• W2000479721 cites W2057407876 @default.
• W2000479721 cites W2057410639 @default.
• W2000479721 cites W2058197822 @default.
• W2000479721 cites W2058514432 @default.
• W2000479721 cites W2060112129 @default.
• W2000479721 cites W2067216327 @default.
• W2000479721 cites W2067902437 @default.
• W2000479721 cites W2068888525 @default.
• W2000479721 cites W2075043109 @default.
• W2000479721 cites W2076140273 @default.
• W2000479721 cites W2086236919 @default.
• W2000479721 cites W2089748070 @default.
• W2000479721 cites W2094109323 @default.
• W2000479721 cites W2098657830 @default.
• W2000479721 cites W2102528806 @default.
• W2000479721 cites W2103422183 @default.
• W2000479721 cites W2107277218 @default.
• W2000479721 cites W2112694389 @default.
• W2000479721 cites W2121891359 @default.
• W2000479721 cites W2128367294 @default.
• W2000479721 cites W2129570913 @default.
• W2000479721 cites W2152471765 @default.
• W2000479721 cites W2154236525 @default.
• W2000479721 cites W2159205789 @default.
• W2000479721 cites W2162361973 @default.
• W2000479721 cites W2165386262 @default.
• W2000479721 cites W4245367233 @default.
• W2000479721 doi "https://doi.org/10.1016/j.neuropharm.2014.06.026" @default.
• W2000479721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24998752" @default.
• W2000479721 hasPublicationYear "2014" @default.
• W2000479721 type Work @default.
• W2000479721 sameAs 2000479721 @default.
• W2000479721 citedByCount "63" @default.
• W2000479721 countsByYear W20004797212014 @default.
• W2000479721 countsByYear W20004797212015 @default.
• W2000479721 countsByYear W20004797212016 @default.
• W2000479721 countsByYear W20004797212017 @default.
• W2000479721 countsByYear W20004797212018 @default.
• W2000479721 countsByYear W20004797212019 @default.
• W2000479721 countsByYear W20004797212020 @default.
• W2000479721 countsByYear W20004797212021 @default.
• W2000479721 countsByYear W20004797212022 @default.
• W2000479721 countsByYear W20004797212023 @default.
• W2000479721 crossrefType "journal-article" @default.
• W2000479721 hasAuthorship W2000479721A5001545372 @default.
• W2000479721 hasAuthorship W2000479721A5013136657 @default.
• W2000479721 hasAuthorship W2000479721A5037057754 @default.
• W2000479721 hasAuthorship W2000479721A5075620817 @default.
• W2000479721 hasAuthorship W2000479721A5081142951 @default.
• W2000479721 hasAuthorship W2000479721A5082707086 @default.
• W2000479721 hasConcept C126322002 @default.
• W2000479721 hasConcept C134018914 @default.
• W2000479721 hasConcept C148762608 @default.
• W2000479721 hasConcept C170493617 @default.
• W2000479721 hasConcept C185280430 @default.
• W2000479721 hasConcept C25274449 @default.
• W2000479721 hasConcept C2777180221 @default.

• next